Find News

Filter articles

Showing 31 to 40 of 2788 results

CJEU outlines scope of rights for plant variety owners

EU19-12-2019Sarah Morgan

The Court of Justice of the European Union has today, December 19, outlined the scope of protection held by owners of plant variety rights in a decision involving a variety of mandarin.

Eli Lilly and Eagle Pharma settle antitrust and infringement claims

US18-12-2019Saman Javed

US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.

Nestlé Skin Health has face injection infringement claims thrown out

Switzerland17-12-2019Rory O'Neill

Nestlé Skin Health will not face claims that it misappropriated trade secrets related to a training platform for teaching medical professionals how to perform facial injections, a US court has ruled.

Squire Patton Boggs names new deputy of IP and technology practice group

US17-12-2019Saman Javed

Squire Patton Boggs has appointed Janice Rice to deputy practice group leader of its IP and technology practice, where she will lead the life and health sciences team.

Fed Circuit dismisses Hospira appeal, says it must pay Amgen $70m

US17-12-2019Saman Javed

A subsidiary of Pfizer, Hospira, infringed one of Amgen’s patents and must pay damages of $70 million, the US Court of Appeal for the Federal Circuit has affirmed.

Senators demand USPTO probe into Gilead allegations

US16-12-2019Rory O'Neill

The US Patent and Trademark Office is coming under increasing pressure to review allegations that Gilead delayed development of its latest HIV drug in order to maximise profits.

US Senate confirms Stephen Hahn as FDA head

US16-12-2019Saman Javed

In a 72-18 vote, the US Senate has confirmed Stephen Hahn as the new commissioner of the Food and Drug Administration.

Merck & Co in $2.7bn cancer research acquisition

12-12-2019Rory O'Neill

Merck & Co has announced its acquisition of cancer research biotech ArQule in a $2.7 billion deal.

Momenta to pay $35m to end enoxaparin class-action suit

12-12-2019Rory O'Neill

Momenta Pharmaceuticals has agreed to pay $35 million to settle a 2015 class-action suit that claimed that it blocked generics of the blockbuster blood clot drug enoxaparin from coming to market.

New USMCA agreement scraps ten-year marketing exclusivity provision

Canada, Mexico, US12-12-2019Saman Javed

The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.

Showing 31 to 40 of 2788 results